Literature DB >> 22968136

Expanding the MTM1 mutational spectrum: novel variants including the first multi-exonic duplication and development of a locus-specific database.

Jorge Oliveira1, Márcia E Oliveira, Wolfram Kress, Ricardo Taipa, Manuel Melo Pires, Pascale Hilbert, Peter Baxter, Manuela Santos, Henk Buermans, Johan T den Dunnen, Rosário Santos.   

Abstract

Myotubular myopathy (MIM#310400), the X-linked form of Centronuclear myopathy (CNM) is mainly characterized by neonatal hypotonia and inability to maintain unassisted respiration. The MTM1 gene, responsible for this disease, encodes myotubularin - a lipidic phosphatase involved in vesicle trafficking regulation and maturation. Recently, it was shown that myotubularin interacts with desmin, being a major regulator of intermediate filaments. We report the development of a locus-specific database for MTM1 using the Leiden Open Variation database software (http://www.lovd.nl/MTM1), with data collated for 474 mutations identified in 472 patients (by June 2012). Among the entries are a total of 25 new mutations, including a large deletion encompassing introns 2-15. During database implementation it was noticed that no large duplications had been reported. We tested a group of eight uncharacterized CNM patients for this specific type of mutation, by multiple ligation-dependent probe amplification (MLPA) analysis. A large duplication spanning exons 1-5 was identified in a boy with a mild phenotype, with results pointing toward possible somatic mosaicism. Further characterization revealed that this duplication causes an in-frame deletion at the mRNA level (r.343_444del). Results obtained with a next generation sequencing approach suggested that the duplication extends into the neighboring MAMLD1 gene and subsequent cDNA analysis detected the presence of a MTM1/MAMLD1 fusion transcript. A complex rearrangement involving the duplication of exon 10 has since been reported, with detection also enabled by MLPA analysis. It is thus conceivable that large duplications in MTM1 may account for a number of CNM cases that have remained genetically unresolved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968136      PMCID: PMC3641378          DOI: 10.1038/ejhg.2012.201

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  45 in total

1.  Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.

Authors:  Anne-Sophie Nicot; Anne Toussaint; Valérie Tosch; Christine Kretz; Carina Wallgren-Pettersson; Erik Iwarsson; Helen Kingston; Jean-Marie Garnier; Valérie Biancalana; Anders Oldfors; Jean-Louis Mandel; Jocelyn Laporte
Journal:  Nat Genet       Date:  2007-08-05       Impact factor: 38.330

2.  Diagnosis of myotubular myopathy in the oldest known manifesting female carrier: a clinical and genetic study.

Authors:  Isabelle Pénisson-Besnier; Valérie Biancalana; Pascal Reynier; Mireille Cossée; Frédéric Dubas
Journal:  Neuromuscul Disord       Date:  2007-01-23       Impact factor: 4.296

3.  164th ENMC International workshop: 6th workshop on centronuclear (myotubular) myopathies, 16-18th January 2009, Naarden, The Netherlands.

Authors:  Heinz Jungbluth; Carina Wallgren-Pettersson; Jocelyn F Laporte
Journal:  Neuromuscul Disord       Date:  2009-08-14       Impact factor: 4.296

Review 4.  Myotubularin phosphatases: policing 3-phosphoinositides.

Authors:  Fred L Robinson; Jack E Dixon
Journal:  Trends Cell Biol       Date:  2006-07-07       Impact factor: 20.808

5.  Extreme phenotypic variability in a German family with X-linked myotubular myopathy associated with E404K mutation in MTM1.

Authors:  Sabine Hoffjan; Charlotte Thiels; Matthias Vorgerd; Eva Neuen-Jacob; Jörg T Epplen; Wolfram Kress
Journal:  Neuromuscul Disord       Date:  2006-09-26       Impact factor: 4.296

6.  Mutations in dynamin 2 cause dominant centronuclear myopathy.

Authors:  Marc Bitoun; Svetlana Maugenre; Pierre-Yves Jeannet; Emmanuelle Lacène; Xavier Ferrer; Pascal Laforêt; Jean-Jacques Martin; Jocelyn Laporte; Hanns Lochmüller; Alan H Beggs; Michel Fardeau; Bruno Eymard; Norma B Romero; Pascale Guicheney
Journal:  Nat Genet       Date:  2005-10-16       Impact factor: 38.330

Review 7.  MAMLD1 (CXorf6): a new gene for hypospadias.

Authors:  T Ogata; Y Wada; M Fukami
Journal:  Sex Dev       Date:  2008-11-05       Impact factor: 1.824

8.  "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.

Authors:  Jorge A Bevilacqua; Marc Bitoun; Valérie Biancalana; Anders Oldfors; Gisela Stoltenburg; Kristl G Claeys; Emmanuelle Lacène; Guy Brochier; Linda Manéré; Pascal Laforêt; Bruno Eymard; Pascale Guicheney; Michel Fardeau; Norma Beatriz Romero
Journal:  Acta Neuropathol       Date:  2008-12-16       Impact factor: 17.088

Review 9.  Centronuclear (myotubular) myopathy.

Authors:  Heinz Jungbluth; Carina Wallgren-Pettersson; Jocelyn Laporte
Journal:  Orphanet J Rare Dis       Date:  2008-09-25       Impact factor: 4.123

10.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

View more
  14 in total

Review 1.  Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients.

Authors:  Qi Wang; Meng Yu; Zhiying Xie; Jing Liu; Qingqing Wang; He Lv; Wei Zhang; Yun Yuan; Zhaoxia Wang
Journal:  Neurol Sci       Date:  2021-09-30       Impact factor: 3.307

2.  A Hunter Patient with a Severe Phenotype Reveals Two Large Deletions and Two Duplications Extending 1.2 Mb Distally to IDS Locus.

Authors:  Alessandra Zanetti; Rosella Tomanin; Angelica Rampazzo; Chiara Rigon; Nicoletta Gasparotto; Matteo Cassina; Maurizio Clementi; Maurizio Scarpa
Journal:  JIMD Rep       Date:  2014-07-25

3.  New massive parallel sequencing approach improves the genetic characterization of congenital myopathies.

Authors:  Jorge Oliveira; Ana Gonçalves; Ricardo Taipa; Manuel Melo-Pires; Márcia E Oliveira; José Luís Costa; José Carlos Machado; Elmira Medeiros; Teresa Coelho; Manuela Santos; Rosário Santos; Mário Sousa
Journal:  J Hum Genet       Date:  2016-02-04       Impact factor: 3.172

4.  A mutation in MTM1 causes X-Linked myotubular myopathy in Boykin spaniels.

Authors:  Natasha J Olby; Steven Friedenberg; Kathryn Meurs; Dylan DeProspero; Julien Guevar; Jeanie Lau; Oriana Yost; Ling T Guo; G Diane Shelton
Journal:  Neuromuscul Disord       Date:  2020-03-05       Impact factor: 4.296

5.  Spectrum of Clinical Features in X-Linked Myotubular Myopathy Carriers: An International Questionnaire Study.

Authors:  Stacha F I Reumers; Frederik Braun; Jennifer E Spillane; Johann Böhm; Maartje Pennings; Meyke Schouten; Anneke J van der Kooi; A Reghan Foley; Carsten G Bönnemann; Erik-Jan Kamsteeg; Corrie E Erasmus; Ulrike Schara-Schmidt; Heinz Jungbluth; Nicol C Voermans
Journal:  Neurology       Date:  2021-05-19       Impact factor: 11.800

6.  X-linked myotubular myopathy in Rottweiler dogs is caused by a missense mutation in Exon 11 of the MTM1 gene.

Authors:  G Diane Shelton; Branden E Rider; Georgina Child; Sophia Tzannes; Ling T Guo; Behzad Moghadaszadeh; Emily C Troiano; Bianca Haase; Claire M Wade; Alan H Beggs
Journal:  Skelet Muscle       Date:  2015-01-27       Impact factor: 4.912

7.  Chimeric Genes in Deletions and Duplications Associated with Intellectual Disability.

Authors:  Sonia Mayo; Sandra Monfort; Mónica Roselló; Carmen Orellana; Silvestre Oltra; Alfonso Caro-Llopis; Francisco Martínez
Journal:  Int J Genomics       Date:  2017-05-24       Impact factor: 2.326

8.  Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort.

Authors:  Fabiana Fattori; Lorenzo Maggi; Claudio Bruno; Denise Cassandrini; Valentina Codemo; Michela Catteruccia; Giorgio Tasca; Angela Berardinelli; Francesca Magri; Marika Pane; Anna Rubegni; Lucio Santoro; Lucia Ruggiero; Patrizio Fiorini; Antonella Pini; Tiziana Mongini; Sonia Messina; Giacomo Brisca; Irene Colombo; Guja Astrea; Chiara Fiorillo; Cinzia Bragato; Isabella Moroni; Elena Pegoraro; Maria Rosaria D'Apice; Enrico Alfei; Marina Mora; Lucia Morandi; Alice Donati; Anni Evilä; Anna Vihola; Bjarne Udd; Pia Bernansconi; Eugenio Mercuri; Filippo Maria Santorelli; Enrico Bertini; Adele D'Amico
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

9.  Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers.

Authors:  Marco Savarese; Olimpia Musumeci; Teresa Giugliano; Anna Rubegni; Chiara Fiorillo; Fabiana Fattori; Annalaura Torella; Roberta Battini; Carmelo Rodolico; Aniello Pugliese; Giulio Piluso; Lorenzo Maggi; Adele D'Amico; Claudio Bruno; Enrico Bertini; Filippo Maria Santorelli; Marina Mora; Antonio Toscano; Carlo Minetti; Vincenzo Nigro
Journal:  Neuromuscul Disord       Date:  2016-02-17       Impact factor: 4.296

10.  Human MAMLD1 Gene Variations Seem Not Sufficient to Explain a 46,XY DSD Phenotype.

Authors:  Núria Camats; Mónica Fernández-Cancio; Laura Audí; Primus E Mullis; Francisca Moreno; Isabel González Casado; Juan Pedro López-Siguero; Raquel Corripio; José Antonio Bermúdez de la Vega; José Antonio Blanco; Christa E Flück
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.